Uji Aktivitas Teh Celup Fraksi Metanol Rimpang Temu Mangga (Curcuma mangga Valeton and Zijp) sebagai Antihiperlipidemia

Antihyperlipidemic Activity of Brewed Methanol Fraction from Temu Mangga Rhizome (Curcuma mangga Valeton and Zijp)

Authors

DOI:

https://doi.org/10.33084/jsm.v7i2.3199

Keywords:

Temu Mangga’s Rhizome, Statins, Cholesterol

Abstract

The high number of deaths from cardiovascular disease in the world makes cardiovascular drugs, such as antihyperlipidemic or dyslipidemia often used by patients in the whole world. Statins are first-line drugs that are often used, but have various side effects, such as myalgia, rhabdomyolysis, and are considered to trigger diabetes mellitus. Meanwhile, the use of traditional medicines such as the Temu mangga’s rhizome (Curcuma mangga Valeton and Zijp) is often used by the community as antihyperlipidemic therapy. The purpose of this study was to scientifically prove the antihyperlipidemic activity of teabags from the methanol fraction of Temu Mangga’s rhizome in reducing lipid profiles, namely total cholesterol, triglycerides, and LDL, as well as increasing HDL. This research method is experimental by measuring the parameters of total cholesterol, triglycerides, LDL, and HDL as well as the bodyweight of the test animals as additional parameters. The test group was divided into 3 doses, namely 0.35 mg, 0.7 mg, and 1.4 mg per 200 grams of test animals. The results showed that there was no significant difference between all groups, both in lipid profile and bodyweight of the test animals. However, a dose of 1.4 mg had better triglyceride lowering activity than the positive control, and the activity of the methanol fraction of the Temu Mangga’s rhizome was predicted to be similar to statins.

Downloads

Download data is not yet available.

References

1. Kementerian Kesehatan RI Badan Penelitian dan Pengembangan (2018) ‘Hasil Utama Riset Kesehatan Dasar’, Kementrian Kesehatan Republik Indonesia, pp. 1–100. Available at: http://www.depkes.go.id/resources/download/info-terkini/hasil-riskesdas-2018.pdf.
2. Kemenkes RI (2014) ‘Situasi kesehatan jantung’, Pusat data dan informasi kementerian kesehatan RI, p. 3. doi: 10.1017/CBO9781107415324.004.
3. Erwinanto et al. (2017) Panduan Tata Laksana Dislipidemia 2017, Jurnal Kardiologi Indonesia. Perhimpunan Dokter Spesialis Kardiovaskular Indonesia.
4. Grundy, S. M. et al. (2019) ‘2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines’, Journal of the American College of Cardiology, 73(24), pp. e285–e350. doi: 10.1016/j.jacc.2018.11.003.
5. Noval, N., Hakim, A. R. and Irawan, A. (2017) ‘Antipyretic Effects of (phaleria macrocarpa (scheff) boerl.) Infusa In Mice Galur Wistar As Animal Model BT - Proceedings of the 2nd Sari Mulia International Conference on Health and Sciences 2017 (SMICHS 2017)’, in. Atlantis Press, pp. 359–368. doi: https://doi.org/10.2991/smichs-17.2017.44.
6. Noval, N. and Raihana, R. (2019) ‘Efek Ekstrak Etanol Akar Pasak Bumi (Eurycoma Longifolia, Jack) terhadap Ekspresi HRAS pada Organ Hati Tikus Galur Sprague Dawley pada Pemberian Doxorubicin’, Jurnal Surya Medika (JSM), 5(1 SE-Articles). doi: 10.33084/jsm.v5i1.952.
7. Nugraha, D. F., Henjani, N. and Magfirah, N. W. (2021) ‘Perbandingan Aktivitas Antihiperlipidemia Infusa Rimpang Temu Mangga dan Daun Ketepeng Cina Comparison of Antihyperlipidemic Activity Temu Mangga ’ s Rhizomes and Ketepeng Cina ’ s Leaves Infusion’, Journal of Pharmacy and Science, 6(2), pp. 81–87.
8. Thompson, P. D. et al. (2016) ‘Statin-associated side effects’, Journal of the American College of Cardiology, 67(20), pp. 2395–2410. doi: 10.1016/j.jacc.2016.02.071.
9. Galicia-Garcia, U. et al. (2020) ‘Statin treatment-induced development of type 2 diabetes: From clinical evidence to mechanistic insights’, International Journal of Molecular Sciences, 21(13), pp. 1–25. doi: 10.3390/ijms21134725.
10. Arifin, B. and Ibrahim, S. (2018) ‘Struktur, Bioaktivitas Dan Antioksidan Flavonoid’, Jurnal Zarah, 6(1), pp. 21–29. doi: 10.31629/zarah.v6i1.313.
11. Tristantini, D. et al. (2016) ‘Pengujian Aktivitas Antioksidan Menggunakan Metode DPPH pada Daun Tanjung ( Mimusops elengi L )’, Universitas Indonesia, p. 2.
12. Mordi, I. et al. (2016) ‘Endothelial dysfunction in human essential hypertension’, Journal of Hypertension, 34(8). Available at: https://journals.lww.com/jhypertension/Fulltext/2016/08000/Endothelial_dysfunction_in_human_essential.3.aspx.
13. Nugraha, D. F. and Yuwindry, I. (2021) ‘Analisis Kasus Hipertensi Pasca Banjir di Wilayah Terdampak: Hantakan & Batu Benawa’, DINAMIKA KESEHATAN: JURNAL KEBIDANAN DAN KEPERAWATAN; Vol 12, No 1 (2021): Dinamika Kesehatan: Jurnal Kebidanan dan Keperawatan. doi: 10.33859/dksm.v12i1.720.
14. Artha, C., Mustika, A. and Sulistyawati, S. W. (2017) ‘Pengaruh Ekstrak Daun Singawalang Terhadap Kadar LDL Tikus Putih Jantan Hiperkolesterolemia’, eJournal Kedokteran Indonesia, 5(2), pp. 105–109. doi: 10.23886/ejki.5.7151.
15. Zeka, K. et al. (2017) ‘Flavonoids and Their Metabolites: Prevention in Cardiovascular Diseases and Diabetes’, Diseases, 5(3), p. 19. doi: 10.3390/diseases5030019.
16. Redberg, R. F. (2014) ‘Statins and Weight Gain’, JAMA Internal Medicine, 174(7), p. 1046. doi: 10.1001/jamainternmed.2014.1994.
17. Al-Bayyari, N. et al. (2017) ‘Assessment of atorvastatin effect on body weight and blood glucose levels among diabetic and non-diabetic patients’, Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, 24(3), pp. 255–262. doi: 10.1515/rjdnmd-2017-0031

Downloads

Published

2022-02-01

How to Cite

Nugraha, D. F., Noval, N., & Nastiti, K. (2022). Uji Aktivitas Teh Celup Fraksi Metanol Rimpang Temu Mangga (Curcuma mangga Valeton and Zijp) sebagai Antihiperlipidemia: Antihyperlipidemic Activity of Brewed Methanol Fraction from Temu Mangga Rhizome (Curcuma mangga Valeton and Zijp). Jurnal Surya Medika (JSM), 7(2), 20–26. https://doi.org/10.33084/jsm.v7i2.3199